IL28B Genetic Variation Is Associated with Spontaneous Clearance of Hepatitis C Virus, Treatment Response, Serum IL-28B Levels in Chinese Population-Reference-Cited by-同舟云学术

IL28B Genetic Variation Is Associated with Spontaneous Clearance of Hepatitis C Virus, Treatment Response, Serum IL-28B Levels in Chinese Population

Published:2012-05-23 Issue:5 Volume:7 Page:e37054
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Shi Xiaodong,Pan Yu,Wang Moli,Wang Dongsheng,Li Wanyu,Jiang Tao,Zhang Peng,Chi Xiumei,Jiang Yanfang,Gao Yanhang,Zhong Jin,Sun Bing,Xu Damo,Jiang Jing,Niu Junqi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. The global burden of hepatitis C. Liver Int;D Lavanchy,2009

2. NIH Consens State Sci Statements;C: NIH Consensus Statement on Management of hepatitis,2002

3. Peginterferon alfa-2b plus ribavirin compared with interferonalfa-2b plus ribavirin for initial treatment of chronic hepatitis C:a randomised trial.;M Manns;Lancet,2001

4. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virusinfection.;M Fried;N Engl J Med,2002

5. Peginterferon -alph2a and ribavirin combination therapy inchronic hepatitis C: a randomized study of treatment duration and ribavirindose.;S Hadziyannis;Ann Intern Med,2004

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Its all about IFN‐λ4: Protective role of IFNL4 polymorphism against COVID‐19‐related pneumonia in females;Journal of Medical Virology;2023-10

2. Functional genetic variants of the IFN-λ3 (IL28B) gene and transcription factor interactions on its promoter;Cytokine;2021-06

3. SNPs of the IFNL favour spontaneous clearance of HCV infection in children;Pediatric Research;2021-05-08

4. Interferon-λ3 Gene Polymorphic Variants, rs4803217 and rs12980275, Responsiveness to HBV Vaccine and Outcome of HBV and HCV Exposure in Hemodialyzed Patients;Hepatitis Monthly;2021-04-18

5. The Key Roles of Interferon Lambda in Human Molecular Defense against Respiratory Viral Infections;Pathogens;2020-11-26